The common FcRg, an immunoreceptor tyrosine-based activation motif (ITAM)-containing adaptor protein, associates with multiple leukocyte receptor complexes and mediates signal transduction through the ITAM in the cytoplasmic domain. The presence of multiple serine and threonine residues within this motif suggests the potential for serine/threonine phosphorylation in modulating signaling events. Single-site mutational analysis of these residues in RBL-2H3 cells indicates that each may contribute to net FcRg-mediated signaling, and mass spectrometry of WT human FcRg from receptorstimulated cells shows consistent preferential phosphorylation of the serine residue at position 51. Immunoblot analysis, mass spectrometry, and mutational analyses showed that phosphorylation of serine 51 in the 7-residue spacer between the 2 YxxL sequences regulates FcRg signaling by inhibiting tyrosine phosphorylation at the membrane proximal Y47 position of the ITAM, but not phosphorylation at position Y58. This inhibition results in reduced Syk recruitment and activation. With in vitro kinase assays, PKC-d and PKA show preferential phosphorylation of S51. Serine/threonine phosphorylation of the FcRg ITAM, which functions as an integrator of multiple signaling elements, may explain in part the contribution of variants in PKC-d and other PKC isoforms to some autoimmune phenotypes.
Introduction
FcRg, an ITAM-containing membrane adaptor protein, noncovalently associates with several immunoglobulin Fc region ligand-binding receptor complexes, including FcgRI, FcgRIII, FceRI, and FcaRI [1] [2] [3] [4] . These FcRg-associated receptors are important modulators of the immune system and provide a crucial link between the innate and adaptive immune systems [5] . The importance of FcRg in immune system regulation and disease has been demonstrated, not only for humoral immunity, but also in humans by the remarkable finding that the FcRg chain replaces the CD3z chain in the TCR CD3 complex in patients with SLE [6] . Further highlighting the importance of FcRg in disease, FcRg-deficient mice which have multiple effector cell defects [7] [8] [9] also have altered autoimmune disease [10] [11] [12] [13] [14] .
Along with supporting the cell surface expression of some receptors, FcRg is critical for receptor complex signaling through its ITAM [15, 16] . After receptor aggregation on the cell surface, FcRg-dependent signaling engages the canonical Src-ITAM-Syk pathway beginning with phosphorylation of ITAM tyrosines by a Src family kinase to form docking sites for the SH2 domains in Syk kinase. Once recruited to the ITAM, Syk becomes activated and phosphorylates downstream signaling intermediates, resulting in the execution of cellular effector programs.
Consistent with its importance in maintenance of immunity, net FcRg function is regulated by several molecular mechanisms. Although IFN-g increases the expression of FcRg in myeloid cells [17] , epigenetic programs regulate net FcRg-mediated activity by reducing FcRg surface expression [18, 19] , and alternatively spliced forms of FcRg with altered function have been identified recently (Gibson, A.W., unpublished data).
Within the context of the YxxL-x n -YxxL motif, the protein sequences vary, both across species and across specific ITAM adaptor proteins within species (Supplemental Tables 1 and 2 ). These ITAMs contain at least 1 serine or threonine, and serine/ threonine phosphorylation of rodent and human FcRg has been documented [20, 21] . However, outside of threonine (T60) in the membrane distal SH2 docking site (YxxL) of rodents [21] , neither the phosphorylation at specific position(s) in the ITAM spacer nor the functional consequence of such phosphorylation is understood. Given the high density of serine/threonine residues in the human g chain ITAM (43% of available positions; Supplemental Table 2 ), we considered the possibility that site-specific serine/threonine phosphorylation within the -x n -ITAM spacer plays an important role in regulating human FcRgmediated responses. These dynamic posttranslational modifications could provide, in part, the basis for regulation of distinct functions ranging from cytokine production to phagocytosis.
Because myeloid-derived cell lines express endogenous FcRg, which may confound analyses, we used the FcRg-deficient RBL-2H3 subline [22] to examine the effects of human FcRg mutants on signal transduction. Observations from RBL-2H3 cells stably expressing HA-tagged human FcRg WT or point mutants show that the several serine and threonine residues within the -x n -ITAM spacer region between the 2 YxxL modules can differentially affect FcRg function. The serine at position 51 (S51) is consistently and predominantly phosphorylated in stimulated cells. Phosphorylation of S51 inhibits FcRg function by reducing phosphorylation of tyrosine 47 in the ITAM, resulting in reduced Syk recruitment and activation. In vitro, S51 is phosphorylated by PKC-d and PKA, variants of which are associated with altered immune system function [23] [24] [25] [26] [27] [28] [29] . Our results indicate that S51 in the human FcRg plays a dampening role in receptor signaling mediated through Syk activation and suggest a novel phosphoserine-based mechanism for regulating human FcRg ITAM signaling. The modifying kinases and phosphatases will provide targets for potential therapeutic intervention in immune complex-mediated diseases.
MATERIALS AND METHODS

Cell culture and reagents
The anti-phosphoserine antibody (clone 16B4; Enzo Life Sciences, Farmingdale, NY, USA) has been shown to detect phosphorylated S51 in FcRg using PKC-d-phosphorylated GST-FcRg fusions in which all threonines and serines, except S51, were changed to alanines (see Fig. 4B, Supplemental Fig.  1 ). The specificity of 16B4 for phosphoserine has also been validated [30] . The anti-FcRg (7D3) and anti-HA (12CA5) monoclonal antibodies were prepared from hybridoma lines in the University of Alabama at Birmingham Epitope Recognition and Immunoreagent Core Facility. Mouse IgE was from BD Biosciences (Franklin Lakes, NJ, USA). The FcRg-deficient RBL-2H3 subline was created by mutagenizing FcRg-sufficient RBL-2H3 cells and selecting clones deficient in FceRI and FcRg expression [22] . The subline cells were a gift from Dr. Juan Rivera [National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Bethesda, MD, USA) and were stably transfected with HA-tagged human FcRg, which restores FceRI surface expression. Εxpression of HA-FcRg was confirmed by surface staining with 20 mg/ml 12CA5, by intracellular staining with 1 mg/ml 7D3, and by increased IgE staining (5 mg/ml) of transfectants followed by FITC-labeled GaM IgG [21] . For FACS sorting, transfectants were stained with 12CA5 followed by FITC-conjugated GaM, and sorted for equivalent expression. Transfectants were also stained with mouse anti-rat CD32B mAb (clone D34-485; BD Biosciences) and FITC-GaM to monitor levels of endogenous CD32B. The HA-tagged (N-terminus) human FcRg expression plasmid was constructed by cloning human FcRg open reading frame containing BamHI ends, without the signal sequence, into the BglII site of the HA-containing pDISPLAY vector (Thermo Fisher Scientific, Carlsbad, CA, USA). Mutant FcRg constructs encoding serine/threonine to alanine mutations (T48A, S51A, T52A, T57A, and T60A) and serine to aspartic acid (S51D) were created by mutagenesis of the HA-FcRg plasmid using sitespecific mutagenic primers (Supplemental Table 4 ) and the QuikChange sitedirected mutagenesis kit (Agilent Technologies, Santa Clara, CA, USA). All mutations were confirmed by DNA sequencing with ABI Prism BigDye terminator cycle sequencing (Thermo Fisher Scientific) performed in the UAB Heflin Sequencing Core Facility.
ELISA and calcium flux
For ELISA, cells were opsonized with 12CA5 (40 mg/ml), mIgE (10 mg/ml), or control antibody (mIgG1, 40 mg/ml) for 30 min at 4°C, washed, and then stimulated with F(ab9) 2 GaM (H+L) secondary antibody for 30 min at 37°C, before incubating in 24-well plates with complete medium for 15-18 h at 37°C. The supernatant was then collected and assayed by ELISA for rat IL-4 cytokine (BD Biosciences). For calcium flux assays, cells were loaded with Indo-1 AM dye (Thermo Fisher Scientific) for 40 min at 37°C, opsonized with 12CA5, and stimulated with F(ab9) 2 pelleting, and freezing pellets at 280°C. Pellets were subsequently lysed in RIPA buffer (Thermo Fisher Scientific) containing inhibitors as above and FcRg immunoprecipitated using bead-adsorbed 7D3. Immunoprecipitates were boiled in 13 SDS loading buffer containing 0.143 M 2-ME, separated on reducing SDS-PAGE, and transferred to nitrocellulose membranes. The membranes blocked with PBS containing 5% BSA before incubation overnight with blotting antibodies (16B4 was used at 1:500 dilution, and 7D3, 4G10, anti-Syk, and anti-p-Syk at 1:1000 dilution). Blots were then washed 3 times with PBS containing 0.1% Tween-20, incubated with HRP-conjugated anti-mouse IgG or anti-rabbit IgG (Jackson ImmunoResearch, West Grove, PA, USA), and after 3 more washes, bound Ab was detected by using ECL (BD Biosciences) according to the manufacturer's directions. The membranes were stripped by incubating with 10 mM Tris-HCl (pH 2.3) containing 0.15 M NaCl, 0.143 M 2-ME, and 2% SDS for 30 min or by incubating with BlotStrip (Thermo Fisher Scientific) for 10 min at room temperature and then blocked and reprobed as described above.
In vitro kinase assays
Glutathione beads loaded with 10 mg GST protein, GST-FcRg CY (fusion of GST and the cytoplasmic domain of FcRg) protein, or serine-to-alanine mutants of FcRg CY were incubated with 2 mCi [ 32 P]-ATP and purified recombinant PKA or PKC isoforms according to the manufacturer's instructions (SignalChem, Richmond, BC, Canada). Beads were washed twice in 50 mM Tris-HCl, 5 mM EDTA (pH 8.5), and 0.5 M NaCl, resuspended in 23 SDS buffer, and electrophoresed on 15% agarose gels. Gels were then dried on Whatman 2 mm paper (GE Healthcare, Pittsburgh, PA, USA) and exposed to film for 2-24 h.
Mass spectrometry
HA-tagged human FcRg was immunoprecipitated from unstimulated and stimulated RBL-2H3 cells using 12CA5 (unstimulated) or donkey anti-goat IgG (stimulated) preadsorbed to protein G beads. Beads were washed 3 times and immunoprecipitates were separated on reducing SDS-PAGE. FcRg protein bands from gels were then analyzed [31] . The gels were stained with Coomassie brilliant blue dye, and slices from SDS-PAGE gels were reduced, carbidomethylated, dehydrated, and digested with trypsin gold (Promega, Madison, WI, USA), per the manufacturer's instructions. After digestion, peptides were extracted, concentrated under a vacuum, and resolubilized in 0.1% formic acid before analysis by 1D reverse-phase liquid chromatographyelectrospray ionization-mass spectrometry-2. Peptide digests were injected (in duplicate) onto a Surveyor HPLC plus (Thermo Fisher Scientific). This system runs in-line with a Thermo Orbitrap Velos Pro hybrid mass spectrometer, equipped with a nano-electrospray source (Thermo Fisher Scientific); all data were collected in collision-induced dissociation mode. Peptide fractions were directly sprayed into the mass spectrometer over a 90 min gradient set to increase from 0-30% acetonitrile in D.I H 2 O containing 0.1% formic acid. After each parent ion scan, fragmentation data were collected on the top most intense 18 ions. The fragmentation scans were obtained at 60 K resolution with a minimum signal threshold of 2000 counts, with activation settings at charge state 3, isolation width 2.0 m/z, normalized collision energy 30.0, activation Q 0.250, and activation time of 25 ms. For the dependent scans, charge-state screening was enabled, and the dynamic exclusion was enabled (with settings: repeat count 2, repeat duration 15.0 s, exclusion list size 500, and exclusion duration 60.0 s). The XCalibur RAW files were collected in profile mode, centroided, and converted to MzXML using ReAdW v. 3.5.1 (http://www.ionsource.com/functional_reviews/readw/t2x_update_readw. htm/ IonSource LLC, Dublin, CA, USA) The mgf files were then created using MzXML2Search (included in Trans Proteomics Pipeline, v. 3.5; http:// www.proteomecenter.org/software.php/ Seattle Proteome Center, Institute for Systems Biology, Seattle, WA, USA) for all scans with a precursor mass between 350 and 2000 Da. The data were searched with Sequest software (Thermo Fisher Scientific). Searches were performed with a species-specific subset of the UniRef100 database (http://www.uniprot.org/help/uniref), which included common contaminants such as digestion enzymes and human keratin, in addition to sequences specific to these experiments. A list of peptide IDs was generated based on Sequest search results, which were filtered using Scaffold (Protein Science, Meriden, CT, USA) to group all matching peptides, to generate and retain only high-confidence IDs, and to normalize spectral counts across all samples for relative quantification. The filter cutoff values were set at peptide length .5 aa. Peptide probabilities were calculated and set to .90% CI, and protein probabilities were set to .97% CI. Relative quantification across experiments was performed via spectral counting and when relevant, spectral count abundances were normalized between samples.
RESULTS AND DISCUSSION
Ser/Thr residues in the human FcRg ITAM are essential for efficient function Apart from tyrosine residues, which are targeted by Src-family kinases, regulation of FcRg and the roles of serine/threonine residues within the FcRg ITAM remain largely unexplored. To determine whether the serine and threonine residues in the human FcRg ITAM x 7 -spacer region influence ITAM function, we used an FcRg-deficient RBL-2H3 cell line stably expressing HA-tagged human FcRg WT or point mutant versions in which serine at position 51 (S51) and threonines at positions 52 and 57 (T52, T57) had been changed to alanines (Fig. 1A) . In addition, alanine mutants of T48 and T60, residues within the YxxL motifs, were constructed and stably expressed in RBL-2H3 cells. Cells expressing equivalent levels of WT or mutant FcRg (Fig. 1B) were stimulated with anti-HA mAb (12CA5) and GaM IgG cross-linking antibody. Secreted IL-4 cytokine was measured by ELISA, and FcRg mutant release of calcium from intracellular stores in a stimulus-dependent fashion was measured with Indo-1 AM. Compared to FcRg WT, alanine substitutions at positions T48, T57, and T60 significantly reduced IL-4 production after stimulation, suggesting that these residues are necessary for efficient ITAM signaling for IL-4 expression ( Fig. 1C ; P , 0.05 for WT vs. T48 and WT vs. T57; P , 0.01 for WT vs. T60). In contrast, alanine substitutions at S51 and T52 resulted in a significant increase in IL-4 above WT levels, suggesting that the residues at these sites negatively regulate FcRg signaling (P , 0.05 for WT vs. S51 and for WT vs. T52). In addition, whereas substitutions at T48 and S51 gave WT levels of intracellular calcium, substitutions at T52, T57, and T60 consistently gave higher levels of calcium, suggesting that these residues negatively regulate FcRg-mediated intracellular calcium release (Fig. 1D) . Taken together, these data indicate that serine and threonine residues in the ITAM play site-specific differential roles in regulating human FcRg function. Similar and different phenotypes resulting from the same mutant are consistent with previously observed results in Fc receptors. Mutation of CD16 cytoplasmic domain serine/ threonine residues that are phosphorylated by PKC resulted in increased receptor-induced degranulation, but reduced cytokine production and intracellular calcium flux, suggesting that the serine/threonine residues impact multiple receptor signaling pathways [32] .
S51 is phosphorylated predominantly in stimulated cells
Although previous work has shown that human FcRg is serine/ threonine phosphorylated with stimulation [33] , the targeted residues are unknown. Determination of which specific serine/ threonine residues in the FcRg ITAM region are phosphorylated is of particular interest because, with the exception of mouse and rat FcRg, S51 is evolutionarily conserved in FcRg (Supplemental Table 2 ), suggesting a unique functionally important role. To confirm the FcRg S51A phenotype, we measured IL-4 production by IgE-stimulated RBL-2H3 cells expressing FcRg WT or the FcRg S51A mutant. IgE engages endogenously expressed FceRI, which signals through FcRg, and S51A gave significantly higher IL-4 levels (P , 0.03) compared to FcRg WT (Supplemental Fig. 2 ). To determine whether S51 is phosphorylated, RBL-2H3 cells expressing human FcRg were stimulated by cross-linking FcRg for various times at 37°C, and Western blots of immunoprecipitated FcRg were probed with anti-phosphoserine mAb, stripped, and reprobed with anti-FcRg mAb. Blots were scanned for the densitometric ratio of phosphoserine to total FcRg and the average of results in 4 independent experiments was determined. Compared with unstimulated cells (Neg), stimulated cells showed a significant increase in serine-phosphorylated FcRg at 2.5 min after stimulation ( Fig. 2A, The MS results showed that, in addition to shifted ion peaks representing the predicted phosphotyrosines, pY47 and pY58 in the ITAM (Fig. 3A, b5 and y7 ions; and Supplemental Fig. 3, b5 and y5 ions), ion peaks corresponding to phosphorylated S51 were consistently observed in stimulated cells ( Fig. 2B ; b9 and y3 shifted ion peaks). In addition, we observed ion peaks consistent with phosphorylation at positions T57 and T60, although these peaks, unlike S51, were not consistently present (data not shown). Phosphorylation of T60 in the stimulated human FcRg ITAM is consistent with previous reports showing that T60 in the rat FcRg ITAM is phosphorylated by PKC-d in FceRI-stimulated RBL-2H3 cells [20, 21] . Despite the altered IL-4 production phenotype resulting from the T48A, S51A, and T52A mutations (Fig. 1B) , neither T48 nor T52 was commonly phosphorylated at the time points assessed following stimulation. Taken together with results obtained from our site-specific mutants, these data indicate that S51 is consistently phosphorylated after stimulation and is important in FcRg ITAM function.
These data are also consistent with observations of FcRg serine phosphorylation in U937 [34] and threonine phosphorylation in RBL-2H3 cells [35, 36] .
Phosphorylation of S51 negatively regulates signaling
To investigate the role of phosphorylation of S51 in FcRg ITAMmediated signals, we measured quantitative Ca 2+ changes in response to FcRg-stimulation in RBL-2H3 cells expressing equivalent levels of FcRg WT, the FcRg S51A mutant, or an FcRg S51D mutant, which structurally mimics phosphorylation (Fig. 2C) . Compared to FcRg WT, the S51D mutant receptor demonstrated markedly diminished levels of Ca 2+ , whereas the S51A mutant was not different from WT (Fig. 2D) . These results are consistent with a negative regulatory role for pS51 in early FcRg signaling. Furthermore, when receptor-induced IL-4 production was assessed, an assay that requires a much longer sustained response over 18 h, we observed that the S51A mutant, which removes the potential for S51 phosphorylation resulted in significantly increased levels of IL-4 secretion (Fig.  2E ). IL-4 production was unaffected in the S51D mutant, consistent with a model in which phosphorylation of S51 negatively regulates receptor function with S51A, allowing a more sustained cellular response over 18 h resulting in higher levels of IL-4 secretion.
Phosphorylation of S51 specifically modulates phosphorylation of ITAM Y47
To investigate the mechanism through which phosphorylation of S51 may modulate FcRg ITAM-based signaling, we explored tyrosine phosphorylation of the FcRg ITAM by Src kinases. The recruitment of Syk to the phosphorylated ITAM and subsequent Syk activation are critical steps in FcRg-mediated signaling for downstream cellular effector functions, and previous observations have indicated that phosphorylation of each ITAM tyrosine in rat FcRg is regulated independently [37] . Therefore, we wished to determine whether phosphorylation of S51 alters phosphorylation of one or both tyrosines in the human FcRg ITAM and subsequent Syk recruitment and activation. RBL-2H3 cells expressing FcRg WT, S51A, or S51D variants were stimulated with 12CA5 and GaM cross-linking for various times, and FcRg was analyzed by MS to quantify specific phosphorylated tyrosines and by immunoblot analysis to determine the relative levels of phosphotyrosine, coprecipitating Syk and activated phospho-Syk. Phosphotyrosine immunoblots show that, compared with FcRg WT, stimulation of the S51A mutant resulted in modestly increased phosphorylation of ITAM tyrosines at 0.5 and 2.5 min (Fig. 3C) . Stimulation of the S51D mutant resulted in significantly reduced tyrosine phosphorylation. In addition, stimulation of S51A resulted in an increase in coprecipitating Syk and Syk activation (phospho-Syk). In contrast, there was a significant decrease in coprecipitating Syk and Syk activation by S51D. Thus, phosphorylation of S51 inhibits tyrosine phosphorylation of the FcRg ITAM. To determine whether both ITAM tyrosines are similarly affected by S51, we used MS analysis (Fig. 3A) , to quantify the number of fragments containing unphosphorylated or phosphorylated Y47 and Y58 in the FcRg variant ITAMs after stimulation for 2.5 min (the time point showing maximum phosphotyrosine by immunoblot analysis). MS data indicated that a significantly lower percentage of S51D FcRg ITAM was phosphorylated at position Y47 (pY47) compared with both WT and S51A (Fig. 3B) , whereas there was no significant difference in the percentage of modified Y58 among the 3 different ITAM constructs. These data indicate that pS51 specifically modulates tyrosine phosphorylation of the membrane proximal Y47 in the ITAM, but not the distal Y58 residue. The regulation of Y47 by an S51-based mechanism is consistent with recent observations showing differential regulation of the phosphorylation of Y58 and Y47 in the ITAM [37] . The regulation of Y47 phosphorylation by S51 also raises the possibility that phosphorylation of Y58 is regulated by Y58-proximate ITAM threonines. Mutation of T60 in the rat FcRg ITAM results in reduced Syk recruitment and activation [21] . Because phosphorylation of both ITAM tyrosines is a requirement for full FcRg activation of Syk [15, 38] , and Syk binds to pY47 with higher affinity than to pY58 [38] , inhibiting the phosphorylation of Y47 or increasing its dephosphorylation would disrupt the high-affinity binding of Syk resulting in reduced Syk recruitment. SHP-1/2 phosphotyrosine phosphatases are known to be recruited by phospho-ITAMs [39] , and phosphorylation of S51 may function to increase the recruitment of SHP-1/2. Alternatively, the diminished phosphorylation of Y47 associated with pS51 could result from inhibition of the Src kinase activity that targets Y47 during receptor activation.
Our working model is that after receptor clustering, there is Src-mediated phosphorylation of Y58 and Y47 with a counterbalancing increase in phosphorylation of S51 which, in turn, results in reduction of the net phosphorylation of pY47. This effect leads to reduced Syk recruitment and activation and a dampening of the activation signal. This model is consistent with our anti-phosphoserine immunoblot and MS data showing lower levels of pS51 in unstimulated cells and higher levels in stimulated cells (Fig. 2A) .
S51 is phosphorylated by PKA and PKC in vitro
MS analysis showed that S51 of the human FcRg ITAM, as well as T57 and T60, are phosphorylated. To determine which protein kinases modify S51, we initially performed a search of several databases to identify kinase target motifs in the FcRg ITAM region. The results suggested that PKA, CK2, and PKC could phosphorylate S51 (Supplemental Table 3 ). However, our previous work showed that CK2 failed to phosphorylate human FcRg [40] . Therefore, using in vitro kinase assays, we tested the ability of recombinant human PKA and PKC-a, -b, -d, and -e to phosphorylate human FcRg WT, mutant FcRg in which all serines and threonines had been changed to alanines (Fig. 4A,  B) , or mutants in which all serine and threonine residues except S51 were changed to alanines (FcRg Mut+S51). Immobilized GST-FcRg WT fusions or mutants were incubated with [ 32 P]-ATP and recombinant enzymes, then washed, separated on gels by SDS PAGE and exposed to film for 2-24 h. Autoradiographs indicate that PKA robustly phosphorylated S51 (Fig. 4A) . PKC-b, -d, and, to a much lesser extent, -a also phosphorylated S51 (Fig. 4B) . PKC-e failed to phosphorylate S51 to any significant degree.
Human myeloid cells express PKC-a and -b (conventional PKCs that require diacylglycerol and calcium for activation), and PKC-d and -e (the novel PKC, which require diacylglycerol) [41] . That not all PKC isoforms target S51 in FcRg suggests specificity. In addition, several ITAM threonines lie within predicted PKC target motifs (Supplemental Table 3 ), which suggests that PKC isoforms also target these residues. Consistent with this model, PKC-b and -d have been shown to migrate to the membrane of FcgRI-stimulated U937 cells [41, 42] .
Naturally occurring genetic variants of PKA and PKC isoforms are associated with immune complex-related autoimmune diseases. Genetic variants of PKA are associated with rheumatoid arthritis and SLE [29] , whereas variants of PKC-d are associated with SLE [24, 25] and autoimmune lymphoproliferative syndrome [26, 28] . Similarly, variants of PKC-b have been associated with end-stage renal disease in diabetes [23, 27] . These kinase variants with altered function could critically influence the regulation of FcRg function and contribute to pathogenic processes.
In summary, we have shown that specific serine and threonine residues in the human FcRg ITAM are phosphorylated and are essential for normal function. Phosphorylation of S51 regulates FcRg ITAM function by altering tyrosine phosphorylation of Y47, but not Y58, resulting in reduced Syk activation. The regulation of FcRg function by site-specific modification of the serine/threonine residues in the ITAM may contribute to the context-specific tonic and inhibitory functions of FcRg, as well as to the canonical Src-ITAM-Syk signaling pathway. Indeed, altered immune complex diseases in FcRg-deficient mice [8, 9] suggest that perturbation of FcRg signaling function provides an important therapeutic target and an understanding of the kinase variants that modify FcRg, and their functional consequences may lead to identification of specific targets for intervention and management of antibody-mediated disease.
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